Wouter Laroy
Directeur Technique/Scientifique/R&D chez MyCartis NV
Postes actifs de Wouter Laroy
Sociétés | Poste | Début | Fin |
---|---|---|---|
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Directeur Technique/Scientifique/R&D | 01/08/2018 | - |
Sales & Marketing | 01/01/2006 | 01/08/2018 |
Historique de carrière de Wouter Laroy
Formation de Wouter Laroy
Ghent University | Doctorate Degree |
Statistiques
Internationale
Belgique | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Sales & Marketing | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Health Technology |
- Bourse
- Insiders
- Wouter Laroy
- Expérience